Ion Exchange Chromatography (IEX) is a powerful charge-based separation technology for resolving proteins, peptides, oligonucleotides, enzymes, conjugates, and other charged biomolecules with high selectivity. For drug discovery and development teams, the central challenge is not simply choosing an anion exchange (AEX) or cation exchange (CEX) column, but building a robust purification strategy that balances binding capacity, selectivity, recovery, sample stability, impurity clearance, and downstream compatibility. BOC Sciences provides comprehensive IEX services, including method screening, buffer and gradient optimization, preparative purification, charge-variant analysis, fraction characterization, and scalable purification support. Our scientists help pharmaceutical, biotechnology, and CRO teams resolve closely related charge species, remove host-cell-related impurities, enrich target biomolecules, and generate decision-ready chromatographic data for research and process development programs.
We develop customized IEX methods by evaluating target charge behavior, buffer composition, ligand chemistry, pH window, conductivity, and elution strategy. Our work can be integrated with broader analysis and purification programs for complex drug development materials.
Our preparative IEX platform supports the purification of charged biomolecules and synthetic compounds requiring high selectivity, clean fraction separation, and practical recovery. This service can be coordinated with custom purification services for multi-step workflows.
We apply IEX to resolve subtle charge differences, including acidic/basic variants, deamidated species, truncated products, oxidized forms, nucleic acid-related impurities, and salt-associated charge heterogeneity.
BOC Sciences translates optimized analytical and semi-preparative IEX conditions into practical purification workflows, supporting larger sample quantities while maintaining chromatographic resolution and target recovery.
BOC Sciences delivers tailored ion exchange chromatography solutions for charge-based purification, impurity removal, fraction enrichment, and method optimization.
We use anion exchange chromatography to capture or resolve negatively charged molecules, including acidic proteins, nucleic acids, oligonucleotides, and selected conjugates. Method design focuses on pH positioning above the target pI, controlled conductivity, and selective elution of bound species.
Our cation exchange methods are designed for positively charged proteins, peptides, enzymes, and charge variants. We optimize binding pH, salt tolerance, resin chemistry, and elution profiles to improve resolution between closely related species while protecting molecular activity.
BOC Sciences evaluates linear gradients, shallow gradients, step gradients, and pH-driven elution to identify the best separation window. These studies help improve peak spacing, minimize co-elution, and support reproducible fraction collection for difficult samples.
We combine optimized column selection, controlled sample loading, UV monitoring, conductivity tracking, and fraction analytics to isolate target peaks from adjacent impurities. This is especially valuable for charge-variant enrichment and unstable biomolecule purification.
IEX can be combined with size exclusion, reverse phase, affinity, desalting, or chromatography testing workflows to build an orthogonal strategy for complex samples. This approach improves confidence when one separation mode alone cannot fully resolve impurities.
Our preparative workflows control flow rate, column volume, conductivity, elution strength, pooling criteria, and post-purification handling. The result is a practical, scalable IEX process that delivers usable fractions rather than only analytical chromatograms.
BOC Sciences supports a wide range of charged molecules and complex sample matrices. Our IEX services are suitable for early-stage method exploration, preparative purification, charge-variant enrichment, impurity depletion, and fraction preparation for downstream analytical or functional studies.
Submit your sample profile, target molecule information, buffer constraints, and desired output. Our chromatography team will design an IEX strategy tailored to your purification, enrichment, or characterization objective.
We review the molecule type, pI, expected charge state, sample matrix, solubility, stability, impurity profile, and required output. This assessment guides AEX/CEX mode selection, buffer strategy, and the level of purification or characterization needed.
We screen strong and weak ion exchangers, pH conditions, salt concentrations, conductivity ranges, and elution formats. Analytical-scale runs identify the operating window that provides the best balance between binding strength, peak resolution, and recovery.
Optimized conditions are transferred to preparative or semi-preparative purification. Fractions are collected based on UV profile, conductivity, elution position, and project-specific pooling criteria, then assessed using appropriate analytical technologies.
We provide purified or enriched fractions, chromatograms, condition summaries, fraction selection rationale, and method recommendations. When needed, our team supports additional polishing, desalting, concentration, or orthogonal analysis.
Separating acidic and basic variants requires careful control of pH, conductivity, gradient slope, and sample load. BOC Sciences develops high-resolution IEX methods that improve peak spacing and reduce overlap between minor variants, enabling clients to better understand charge heterogeneity and isolate specific species for further characterization or functional comparison.
Strong electrostatic binding can improve capture but may cause poor recovery, broad peaks, or irreversible adsorption. We address this by adjusting ligand strength, buffer pH, salt type, ionic strength, organic modifier compatibility, and elution profile, helping clients recover sensitive proteins, peptides, and oligonucleotides without sacrificing separation selectivity.
Crude reaction mixtures, expression harvests, and partially purified samples often contain salts, surfactants, nucleic acids, host-cell-related proteins, or aggregates that interfere with IEX binding. BOC Sciences designs sample conditioning, dilution, buffer exchange, clarification, and orthogonal purification steps to reduce matrix effects before chromatographic separation.
A condition that looks promising on an analytical column may fail when sample load increases. Our team evaluates dynamic binding capacity, residence time, column geometry, linear velocity, and pooling strategy to translate optimized IEX separations into preparative workflows that deliver practical quantities of usable target material.
Collaborate with BOC Sciences to build practical IEX workflows for biomolecule purification, charge-variant separation, impurity depletion, and scalable fraction preparation. Our team turns difficult charge-based separation problems into structured, data-driven purification solutions.
Every IEX project is designed around the target molecule's pI, charge distribution, stability, matrix composition, and downstream use. This avoids generic conditions that may bind the wrong species or compromise recovery.
Our IEX workflows can be supported by UV profiling, conductivity monitoring, fraction analytics, impurity assessment, and complementary analytical platform capabilities to provide actionable purification data.
We support proteins, enzymes, peptides, oligonucleotides, conjugates, and complex charged mixtures. Our scientists adapt column chemistry, buffer systems, and sample handling to preserve target activity and structural integrity.
BOC Sciences considers load capacity, elution volume, fraction pooling, buffer compatibility, and downstream processing from the beginning, helping clients move from screening data to usable purified material efficiently.
Client Needs: A European biotechnology team needed to resolve acidic and basic variants of a recombinant Fc-fusion protein. Their existing polishing method showed overlapping peaks and inconsistent recovery across multiple small-scale purification runs.
Challenges: The target protein displayed narrow charge differences and partial sensitivity to elevated salt concentration. High sample loading reduced resolution, while shallow gradients increased run time and diluted the desired fractions.
Solution: BOC Sciences screened four cation exchange chemistries, six pH conditions, and three conductivity windows, then built a shallow-to-steep hybrid salt gradient to separate adjacent charge species. We compared 18 analytical runs, selected two candidate methods, and transferred the best condition to semi-preparative purification with defined pooling criteria based on UV profile and conductivity.
Outcome: The optimized IEX method improved separation between the major protein peak and adjacent acidic variants, increased usable recovery, and generated enriched fractions suitable for downstream structural and activity comparison.
Client Needs: A peptide discovery group required purification of a basic cyclic peptide containing multiple lysine and arginine residues. Reverse-phase purification alone left several charged truncation products co-eluting with the target fraction.
Challenges: The peptide showed strong binding to cation exchange media and broadened under high-salt elution. The client also needed a workflow that minimized sample exposure to harsh conditions before downstream biological testing.
Solution: We evaluated weak and strong cation exchangers, adjusted buffer pH to moderate net charge, and introduced a stepwise salt elution program followed by rapid desalting. Across 12 scouting runs, BOC Sciences mapped truncation-product behavior, refined loading mass, and used fraction-level LC analysis to identify the cleanest target-containing pool.
Outcome: The final IEX polishing step removed the dominant charged truncation impurities and provided a concentrated peptide fraction with improved chromatographic profile for subsequent functional evaluation.
Client Needs: A North American nucleic acid research team needed an anion exchange workflow to enrich a phosphorothioate-modified oligonucleotide and reduce shortmers, salt-associated impurities, and late-eluting side products.
Challenges: The oligonucleotide mixture contained species with very similar charge density, and small changes in temperature, pH, or salt composition shifted retention. The client needed practical conditions compatible with follow-up desalting and concentration.
Solution: BOC Sciences developed an anion exchange method using controlled temperature, buffered pH screening, and a segmented salt gradient. We tested 15 gradient profiles, monitored UV response at nucleic-acid-relevant wavelengths, collected narrow fractions, and compared impurity distribution by orthogonal chromatographic analysis before defining the final pooling window.
Outcome: The optimized AEX process separated the major oligonucleotide product from shortmer-enriched fractions, reduced salt-related interference, and delivered a cleaner material stream for downstream experimental use.
Ion Exchange Chromatography (IEX) is well suited for charged biomolecules, including proteins, peptides, oligonucleotides, enzymes, antibodies, antibody fragments, and charge-sensitive modified molecules. It is especially valuable when a project requires separation of charge variants, acidic or basic isoforms, deamidated species, phosphorylated forms, or other molecules with subtle electrostatic differences. BOC Sciences develops IEX methods based on each molecule’s isoelectric point, surface charge distribution, buffer compatibility, and stability profile, helping clients obtain meaningful separation data for purification strategy design, impurity profiling, and downstream analytical development.
IEX separates molecules according to their net surface charge under defined buffer conditions. By carefully selecting anion or cation exchange media, optimizing pH, ionic strength, gradient slope, flow rate, and column chemistry, closely related molecular species can be resolved with high selectivity. For drug development teams, this is particularly useful when standard reversed-phase or size-based methods cannot distinguish charge-related variants. BOC Sciences applies systematic method screening and parameter optimization to improve peak resolution, recovery, and reproducibility, allowing clients to better understand product heterogeneity and make informed purification or characterization decisions.
Yes. BOC Sciences provides customized IEX method development for molecules with different charge behaviors, structural complexity, and sample matrices. Our scientists begin by evaluating molecular properties such as pI, solubility, aggregation tendency, buffer tolerance, and expected impurity profile. Based on these factors, we screen suitable exchange modes, resin chemistries, mobile phases, salt gradients, and detection conditions. This tailored approach helps avoid generic methods that may cause poor resolution, sample loss, or unstable retention. Clients receive method conditions, analytical observations, and practical recommendations that support purification development, process optimization, and comparative sample assessment.
IEX services can help solve common separation challenges such as overlapping charge variants, low-abundance impurity detection, poor peak symmetry, insufficient recovery, matrix interference, and inconsistent retention behavior. These issues often arise in protein, peptide, and complex biologic-related projects where small chemical or conformational changes alter molecular charge. BOC Sciences addresses these challenges through resin screening, buffer system optimization, gradient refinement, sample pretreatment evaluation, and orthogonal analytical comparison when needed. The goal is to generate a robust, interpretable, and project-specific IEX method that helps clients reduce uncertainty and improve decision-making during drug development.
BOC Sciences combines chromatography expertise, molecule-specific method design, and practical drug development experience to deliver reliable Ion Exchange Chromatography services for research and development projects. Rather than applying a fixed workflow, our team adapts each IEX strategy to the client’s target molecule, sample type, analytical objective, and downstream requirements. We support charge variant analysis, purification method development, impurity separation, fraction collection, and method troubleshooting. Clients benefit from clear experimental design, professional data interpretation, and actionable recommendations, helping them accelerate analytical development and strengthen confidence in their molecule’s quality profile.
BOC Sciences helped us redesign a difficult cation exchange method for a recombinant protein with closely spaced charge variants. Their screening logic was clear, and the final fraction profile gave our team much better material for comparison studies.
— Dr. Mason, Director of Protein Sciences
We came to BOC Sciences with a peptide mixture that resisted standard purification. Their IEX polishing strategy removed the charged side products efficiently and gave us a workflow that was practical rather than overly theoretical.
— Chandler, Senior Scientist, Peptide Discovery
The team understood the relationship between pH, conductivity, and target recovery immediately. Their systematic AEX screening helped us identify the right conditions for an oligonucleotide sample with several difficult shortmer impurities.
— Dr. Burke, Nucleic Acid Research Lead
BOC Sciences did more than generate a clean chromatogram. They considered loading, pooling, buffer exchange, and recovery from the beginning, which made the transition from scouting runs to preparative purification much smoother.
— Hughes, CMC Project Manager
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
